The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
MMA CAPITAL HOLDINGS INC | COM | 55315D105 | 2,177 | 72,552 | SH | SOLE | 72,552 | 0 | 0 | ||
ONCONOVA THERAPEUTICS INC | COM NEW | 68232V405 | 524 | 616,389 | SH | SOLE | 616,389 | 0 | 0 | ||
ONCONOVA THERAPEUTICS INC | *W EXP 07/07/202 | 68232V116 | 8 | 390,624 | SH | SOLE | 390,624 | 0 | 0 |